DECITABINE FOR MYELODYSPLASTIC SYNDROME AND ELDERLY ACUTE MYELOID LEUKEMIA -A TERTIARY CENTRE DATA FROM INDIA
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2014, Vol 6, Issue 10
Abstract
Objective: To assess the clinical profile of patients receiving Decitabine for myelodysplastic syndromes (MDS) and Acute myeloid leukemia (AML).Methods: 14 patients had been initiated on Decitabine which included 11 MDS patients and 3 AML patients. Response was defined for MDS according to the International Working Group (IWG) 2006 criteria, whereas for AML according to IWG-AML 2003 criteria. Toxicities were graded according to the National Cancer Institute/Common Toxicity Criteria guidelines, version four.Results: Out of the 14 patients overall response was achieved in 7 patients (50%) including 4 complete remission (29%), 1 partial remission (7%) and 2 stable diseases with hematological improvement (HI-N 1, HI-P 1 (14%). In case of MDS over all response was found in 6 patients (55%) including 3 patients with CR (27.5%), 1 PR (9%) and 2 stable diseases with HI (27%). Out of 14 patients 5 patients showed treatment failure (36%). One MDS patient showed disease progression and other one discontinued Decitabine. The most commonly occurred adverse effect noted was neutropenia which was observed in 13 patients (92.85%) and least commonly occurred were fatigue (13%) and fever (13%).Conclusion Almost similar efficacy and safety profile were observed after comparing our data with ADOPT trial conducted by David P Steensma et al. The patients with MDS and AML had a lower median age at presentation compared with western data. We also noticed a worsening of pre-existing renal dysfunction observed in one patient after the second cycle of Decitabine which reversed upon stopping the drug.Â
Authors and Affiliations
Jincy Eldhose, Glindow Antony, Jithu Joseph, Naveen Kumar Panicker, Neeraj Sidharthan
Keywords
Related Articles
- EP ID EP579502
- DOI -
- Views 93
- Downloads 0
ANALYSIS OF ORAL GLUCOSE TOLERANCE TEST USING MODIFIED ORAL MINIMAL MODEL TO DIAGNOSE OF TYPE 2 DIABETES
Objective: In this paper, a mathematical model with the new insulin system for describing the modified oral minimal model of glucose plasma levels is introduced. This model is combined with non linear least-squares metho...
ASSESSMENT OF GENETIC DIVERSITY IN TINOSPORA CORDIFOLIA BY INTER SIMPLE SEQUENCE REPEATS (ISSR) AND EXPRESSED SEQUENCE TAGGED- SIMPLE SEQUENCE REPEATS (EST-SSR)
Objective: In this study, assessment of genetic diversity was carried out using two kinds of molecular markers: Inter-Simple Sequence Repeats (ISSR) and Expressed Sequence Tag Simple Sequence Repeats (EST-SSR) in T. cord...
FORMULATION AND EVALUATION OF ION-SENSITIVE IN-SITU NASAL GEL OF ZOLMITRIPTAN
In situ gel system is novel drug delivery system in which there is transition of sol to gel on external stimuli like change in pH, temperature or change in ion concentration (sol-gel transition). In the present study var...
COMPOSITION OF PURIFIED ANTHOCYANIN ISOLATED FROM TEAK AND IT’S IN VITRO ANTIOXIDANT ACTIVITY
Objective: The present study evaluates purification, characterization of anthocyanin from in vitro culture of teak and its antioxidant potential.Methods: Anthocyanin was extracted from in vitro culture, purified by using...
A STUDY OF CLINICAL PHARMACIST INITIATED INTERVENTION FOR THE OPTIMAL USE OF MEDICATIONS IN A NEONATAL INTENSIVE CARE UNIT (NICU) OF A TERTIARY CARE HOSPITAL, SOUTH INDIA
Objective: Various strategies to reduce errors have been described in adult and pediatric patients, but there are few published data on their effect in the NICU. The study was carried out to assess the impact of a clinic...